Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with chronic hepatitis B

Journal of Clinical Gastroenterology

Volumn 42, Issue 6, 2008, Pages 738-743

  Koo, Ja Seung ^a,b   Kim, Haeryoung ^c   Park, Byung Kyu ^b   Ahn, Sang Hoon ^b   Han, Kwang Hyub ^b   Chon, Chae Yoon ^b   Park, Chanil ^a,b   Park, Young Nyun ^a,b  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

Hepatitis B virus; Hepatocellular carcinoma; Liver cell dysplasia

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; PROTEIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPLASIA; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CELL; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RISK FACTOR; SCREENING; THROMBOCYTE; LIVER TUMOR; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY;

ADULT; BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B, CHRONIC; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 54749121355     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318038159d     Document Type: Article

References (38)

1. Bosch X, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19:271-285.
2. Beasley R. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer. 1988;61:1942-1956.
3. Yuen M-F, Cheng C-C, Lauder IJ, et al. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology. 2000;31:330-335.
4. McMahon BJ, Bulkow L, Harpster A, et al. Screening for hepatocellular carcinoma in Alaskan natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology. 2000;32: 842-846.
5. Anthony PP, Vogel CL, Barker LF. Liver cell dysplasia: a premalignant condition. J Clin Pathol. 1973;26:217-223.
6. Watanabe S, Okita K, Harada T, et al. Morphologic studies of the liver cell dysplasia. Cancer. 1983;51:2197-2205.
7. Adachi E, Hashimoto H, Tsuneyoshi M. Proliferating cell nuclear antigen in hepatocellular carcinoma and small liver cell dysplasia. Cancer. 1993;72:2902-2909.
8. Roncalli M, Borzio M, Brando B, et al. Abnormal DNA content in liver cell dysplasia: a flow cytometric study. Int J Cancer. 1989;44: 204-207.
9. Thomas RM, Berman JJ, Yetter RA, et al. Liver cell dysplasia: a DNA aneuploid lesion with distinct morphological features. Hum Pathol. 1992;23:496-503.
10. Rubin EM, DeRose PB, Cohen C. Comparative image cytometric DNA ploidy of liver cell dysplasia and hepatocellular carcinoma. Mod Pathol. 1994;7:677-680.
11. Terris B, Ingster O, Rubbia L, et al. Interphase cytogenetic analysis reveals numerical chromosome aberrations in large cell dysplasia. J Hepatol. 1997;27:313-319.
12. Koo JS, Seong JK, Park C, et al. Large liver cell dysplasia in hepatitis B virus X transgenic mouse liver and human chronic hepatitis B virus-infected liver. Intervirology. 2005;48:16-22.
13. Natarajan S, Theise ND, Thung SN, et al. Large-cell change of hepatocytes in cirrhosis may represent a reaction to prolonged cholestasis. Am J Surg Pathol. 1997;21:312-318.
14. Henmi A, Uchida T, Shikata T. Karyometric analysis of liver cell dysplasia and hepatocellular carcinoma. Evidence against precan-cerous nature of liver cell dysplasia. Cancer. 1985;55:2594-2599.
15. Lee RG, Tsamandas AC, Demetris AJ. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis. Hepatology. 1997;26:1415-1422.
16. Batts KP, Ludwig J. Chronic hepatitis: an update on terminology and reporting. Am J Surg Pathol. 1995;19:1409-1417.
17. Roncalli M, Borzio M, de Biagi G, et al. Liver cell dysplasia and hepatocellular carcinoma: a histological and immunohistochemical study. Histopathology. 1985;9:209-221.
18. Su Q, Benner A, Hofmann WJ, et al. Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia. Virchows Arch. 1997;431:391-406.
19. Borzio M, Roncalli M, Trere D, et al. Preneoplastic cellular changes in liver. Hepatology. 1998;28:1435-1436.
20. Libbrecht L, Craninx M, Nevens F, et al. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis. Histopathology. 2001;39:66-73.
21. Lefkowitch JH, Schiff ER, Davis GL, et al. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. Gastroenterology. 1993;104:595-603.
22. Hytiroglou P, Theise ND, Schwartz M, et al. Macroregenerative nodules in a series of adult cirrhotic liver explants: issue of classification and nomenclature. Hepatology. 1995;21:703-708.
23. Le Bail B, Bernard PH, Carles J, et al. Prevalence of liver cell dysplasia and association with HCC in series of 100 cirrhotic liver explants. J Hepatol. 1997;27:835-842.
24. Fracanzani AL, Borzio M, Roncalli M, et al. Can large cell change and high proliferative activity predict hepatocellular carcinoma in patients with hereditary hemochromatosis? Am J Gastroenterol. 2000;95:2940-2945.
25. Esquivel CO, Gutierrez C, Cox KL, et al. Hepatocellular carcinoma and liver cell dysplasia in children with chronic liver disease. J Pediatr Surg. 1994;29:1465-1469.
26. Cohen C, DeRose PB. Liver cell dysplasia in alpha-1-antitrypsin deficiency. Mod Pathol. 1994;7:31-36.
27. Korean National Statistical Office. Annual Report on the Causes of Death Statistics (in Korean). Seoul: Korean National Statistical Office; 2004.
28. Cheon JH, Park JW, Park KW, et al. The clinical report of 1,078 cases of hepatocellular carcinomas: National Cancer Center experience. Korean J Hepatol. 2004;10:288-297.
29. Borzio M, Bruno S, Roncalli M, et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology. 1995;108:812-817.
30. Ganne-Carrie N, Chastang C, Chapel F, et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology. 1996;23:1112-1118.
31. Park YN, Roncalli M. Large liver cell dysplasia: a controversial entity. J Hepatol. 2006;45:734-743.
32. Ho JC, Wu PC, Mak TK. Liver cell dysplasia in association with hepatocellular carcinoma, cirrhosis and hepatitis B surface antigen in Hong Kong. Int J Cancer. 1981;28:571-574.
33. Paradis V, Laurendeau I, Vidaud M, et al. Clonal analysis of macronodules in cirrhosis. Hepatology. 1998;28:953-958.
34. Libbrecht L, Desmet V, Roskams T. Preneoplastic lesions in human hepatocarcinogenesis. Liver Int. 2005;25:16-27.
35. Marchio A, Terris B, Meddeb M, et al. Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation. J Clin Pathol-Mol Pathol. 2001;54:270-274.
36. Libbrecht L, Desmet V, Van Damme B, et al. The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. J Hepatol. 2000;33:76-84.
37. Adachi E, Hashimoto H, Tsuneyoshi M. Proliferating cell nuclear antigen in hepatocellular carcinoma and small cell liver dysplasia. Cancer. 1993;72:2902-2909.
38. Idilman R, De Maria N, Colantoni A, et al. Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma. J Viral Hepat. 1998;5:285-299.